Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage

Stroke

Volumn 46, Issue 1, 2015, Pages 58-64

  Fletcher, Jeffrey J ^a,c   Kotagal, Vikas ^a   Mammoser, Aaron ^a   Peterson, Mark ^b   Morgenstern, Lewis B ^a,b   Burke, James F ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BRONSON METHODIST HOSPITAL   (United States)

Author keywords

cerebral hemorrhage; cost effectiveness; mortality

Indexed keywords

AGED; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; LONG TERM CARE; MAJOR CLINICAL STUDY; NEUROLOGICAL INTENSIVE CARE UNIT; PATIENT TRANSPORT; QUALITY ADJUSTED LIFE YEAR; CEREBRAL HEMORRHAGE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; MIDDLE AGED; MONTE CARLO METHOD; NEUROLOGY; STATISTICAL MODEL;

AGED; CEREBRAL HEMORRHAGE; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; MODELS, ECONOMIC; MONTE CARLO METHOD; NEUROLOGY; PATIENT TRANSFER; QUALITY-ADJUSTED LIFE YEARS;

EID: 84920264260     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006653     Document Type: Article

References (38)

1. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intrace-rebral hemorrhage. Crit Care Med. 2001;29:635-640.
2. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol. 2001;13:83-92.
3. Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J, et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med. 2004;32:2311-2317.
4. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632-1644.
5. Andaluz N, Zuccarello M. Recent trends in the treatment of spontaneous intracerebral hemorrhage: analysis of a nationwide inpatient database. J Neurosurg. 2009;110:403-410.
6. Feng W, Nietert PJ, Adams RJ. Infuence of age on racial disparities in stroke admission rates, hospital charges, and outcomes in South Carolina. Stroke. 2009;40:3096-3101.
7. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43:1711-1737.
8. Bardach NS, Zhao S, Gress DR, Lawton MT, Johnston SC. Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke. 2002;33:1851-1856.
9. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al; American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affrms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711.
10. Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, et al; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-2129.
11. Langhorne P, Fearon P, Ronning OM, Kaste M, Palomaki H, Vemmos K, et al; Stroke Unit Trialists' Collaboration. Stroke unit care benefts patients with intracerebral hemorrhage: systematic review and meta-analysis. Stroke. 2013;44:3044-3049.
12. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute isch-emic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
13. Samsa GP, Reutter RA, Parmigiani G, Ancukiewicz M, Abrahamse P, Lipscomb J, et al. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol. 1999;52:259-271.
14. Hemphill JC III, Farrant M, Neill TA Jr. Prospective validation of the ICH Score for 12-month functional outcome. Neurology. 2009;73:1088-1094.
15. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ. The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology. 2011;77:1590-1598.
16. Silbergleit R, Scott PA, Lowell MJ, Silbergleit R. Cost-effectiveness of helicopter transport of stroke patients for thrombolysis. Acad Emerg Med. 2003;10:966-972.
17. Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke. 2006;37:2751-2758.
18. Lee WC, Christensen MC, Joshi AV, Pashos CL. Long-term cost of stroke subtypes among Medicare benefciaries. Cerebrovasc Dis. 2007;23:57-65.
19. Lott JP, Iwashyna TJ, Christie JD, Asch DA, Kramer AA, Kahn JM. Critical illness outcomes in specialty versus general intensive care units. Am J Respir Crit Care Med. 2009;179:676-683.
20. Adeoye O, Haverbusch M, Woo D, Sekar P, Moomaw CJ, Kleindorfer D, et al. Is ED disposition associated with intracerebral hemorrhage mortality? Am J Emerg Med. 2011;29:391-395.
21. Christensen MC, Morris S. Association between disability measures and short-term health care costs following intracerebral hemorrhage. Neurocrit Care. 2008;9:313-318.
22. Gage BF, Cardinalli AB, Owens DK. Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fbrilla-tion. Stroke. 1998;29:1083-1091.
23. Palm F, Henschke N, Wolf J, Zimmer K, Safer A, Schröder RJ, et al. Intracerebral haemorrhage in a population-based stroke registry (LuSSt): incidence, aetiology, functional outcome and mortality. J Neurol. 2013;260:2541-2550.
24. Bhalla A, Wang Y, Rudd A, Wolfe CD. Differences in outcome and predictors between ischemic and intracerebral hemorrhage: the South London Stroke Register. Stroke. 2013;44:2174-2181.
25. Patel HC, Menon DK, Tebbs S, Hawker R, Hutchinson PJ, Kirkpatrick PJ. Specialist neurocritical care and outcome from head injury. Intensive Care Med. 2002;28:547-553.
26. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al; DECIMAL, DESTINY, and HAMLET Investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215-222.
27. Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50, 000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res. 2008;8:165-178.
28. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ. 2004;329:224-227.
29. Russell LB. Do We Really Value Identifed Lives More Highly Than Statistical Lives? Med Decis Making. 2013;34:556-559.
30. Ho KM, Honeybul S, Lind CR, Gillett GR, Litton E. Cost-effectiveness of decompressive craniectomy as a lifesaving rescue procedure for patients with severe traumatic brain injury. J Trauma. 2011;71:1637-1644, discussion 1644.
31. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology. 1998;50:883-890.
32. Tung CE, Win SS, Lansberg MG. Cost-effectiveness of tissue-type plas-minogen activator in the 3-to 4.5-hour time window for acute ischemic stroke. Stroke. 2011;42:2257-2262.
33. Hofmeijer J, van der Worp HB, Kappelle LJ, Eshuis S, Algra A, Greving JP; HAMLET Steering Committee. Cost-effectiveness of surgical decompression for space-occupying hemispheric infarction. Stroke. 2013;44:2923-2925.
34. Higashida R, Alberts MJ, Alexander DN, Crocco TJ, Demaerschalk BM, Derdeyn CP, et al; American Heart Association Advocacy Coordinating Committee. Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke. 2013;44:2961-2984.
35. Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CC. Cost-effectiveness of stroke unit care followed by early supported discharge. Stroke. 2009;40:24-29.
36. Zahuranec DB, Gonzales NR, Brown DL, Lisabeth LD, Longwell PJ, Eden SV, et al. Presentation of intracerebral haemorrhage in a community. J Neurol Neurosurg Psychiatry. 2006;77:340-344.
37. Wolf SL, Winstein CJ, Miller JP, Thompson PA, Taub E, Uswatte G, et al. Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial. Lancet Neurol. 2008;7:33-40.
38. Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the excite randomized clinical trial. JAMA. 2006;296:2095-2104.